4/A//SEC Filing
SMITH CRAIG R 4/A
Accession 0000002230-18-000026
CIK 0000002230other
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:41 PM ET
Size
9.1 KB
Accession
0000002230-18-000026
Insider Transaction Report
Form 4/AAmended
SMITH CRAIG R
Director
Transactions
- Sale
Common Stock
2018-05-30$15.15/sh−6,666$100,997→ 22,802 total(indirect: By Trust) - Other
Common Stock
2018-03-01+44.594→ 20,364.833 total
Holdings
- 6,666.833
Common Stock
- 15,770(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]These shares were acquired in exempt transactions as a result of dividend reinvestment. The Issuer's stock traded in a range of $14.30 - $16.11 during the first quarter of 2018.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.14 - $15.19. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Shares held of record by Craig Robert Smith, MD, Trustee of the Craig Robert Smith MD REV Trust DTD 3/8/11.
- [F4]Includes shares formerly held directly at the transfer agent that were transferred to the Craig Robert Smith MD REV Trust DTD 3/8/11 (revocable Trust) on May 15, 2018. Effective with the sale that occurred on May 30, 2018 and that was reported on May 31, 2018, Dr. Smith beneficially owns 22,802 total shares indirectly in the revocable Trust, 6,666 shares directly in a tax-deferred individual retirement account (IRA),and a 0.833 fractional share interest at the transfer agent, for a total of 29,468.833 shares.
Documents
Issuer
ADAMS DIVERSIFIED EQUITY FUND, INC.
CIK 0000002230
Entity typeother
Related Parties
1- filerCIK 0000938742
Filing Metadata
- Form type
- 4/A
- Filed
- May 31, 8:00 PM ET
- Accepted
- Jun 1, 4:41 PM ET
- Size
- 9.1 KB